Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 1/20 | 0.48 |
| ▸ | CHKA | P35790 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | HBB | P68871 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11501045 | 0.84 | PYCR1 (0.41) | CHKASMN1; SMN2ALOX15PYCR1 | |
| SCHEMBL1257194 | 0.78 | CA12 (0.42) | SMN1; SMN2MEN1KMT2APYCR1 | |
| SCHEMBL418658 | 0.78 | CHKA (0.46) | CHRM5CHKASLC6A2SMN1; SMN2MAPT | |
| SCHEMBL14415500 | 0.77 | CHRNB2 (0.42) | — | |
| SCHEMBL15590642 | 0.76 | CHRM5 (0.41) | CHRM5CHKASLC6A2SMN1; SMN2MAPT | |
| SCHEMBL2103019 | 0.76 | CHRM5 (0.54) | CHRM5CHKASLC6A2SMN1; SMN2MAPT | |
| SCHEMBL11406187 | 0.75 | ALDH1A1 (0.48) | MAPTMEN1ALOX15KMT2APYCR1 | |
| SCHEMBL3290812 | 0.75 | PYCR1 (0.35) | PYCR1 | |
| SCHEMBL21021269 | 0.75 | APP (0.44) | SLC6A2SMN1; SMN2PYCR1 | |
| SCHEMBL15336561 | 0.75 | APP (0.44) | MAPTMEN1NPC1ALOX15RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0511303-A4 | AMINOPYRIDYL SILANES AND SILOXANES | — | 1993-09-01 | — | — | EP | claimed |
| US-5194555-A | Incorporating dialkylaminopyridine functionality; catalyst for acylation, polymerization, reduction, oxidation | INDIANA UNIVERSITY FOUNDATION (US) | 1993-03-16 | — | — | US | claimed |
| EP-0511303-A1 | AMINOPYRIDYL SILANES AND SILOXANES | INDIANA UNIVERSITY FOUNDATION (US) | 1992-11-04 | — | — | EP | claimed |
| WO-1991010714-A1 | AMINOPYRIDYL SILANES AND SILOXANES | INDIANA UNIVERSITY FOUNDATION (US) | 1991-07-25 | — | — | WO | claimed |
| US-20090082588-A1 | Process for producing fluorinated carbamates and isocyanates | REPSOL YPF, S.A. (ES) | 2009-03-26 | — | — | US | disclosed |
| US-20090082588-A1 | Process for producing fluorinated carbamates and isocyanates | REPSOL YPF, S.A. (ES) | 2009-03-26 | — | — | US | disclosed |
| US-20090082588-A1 | Process for producing fluorinated carbamates and isocyanates | REPSOL YPF, S.A. (ES) | 2009-03-26 | — | — | US | disclosed |
| EP-2036884-A1 | Process for producing fluorinated isocyanates and carbamates | REPSOL YPF S.A. (ES) | 2009-03-18 | — | — | EP | disclosed |
| EP-2036884-A1 | Process for producing fluorinated isocyanates and carbamates | REPSOL YPF S.A. (ES) | 2009-03-18 | — | — | EP | disclosed |
| US-5461020-A | Dialkyl amino pyridine catalysts which are bound to inorganic matrices and processes for their preparation | OLIN CORPORATION (US) | 1995-10-24 | — | — | US | disclosed |
| EP-0607129-B1 | METHYLPIPERAZINOAZEPINE DERIVATIVES, THEIR PREPARATION AND USE | THERABEL RESEARCH SA (BE) | 1995-08-23 | — | — | EP | disclosed |
| US-5442106-A | Hydrolyzing activated ester in aqueous medium with selective catalyst | INDIANA UNIVERSITY FOUNDATION (US) | 1995-08-15 | — | — | US | disclosed |
| US-5393752-A | Psycholigical disorders | THERABEL RESEARCH S.A./N.V. (BE) | 1995-02-28 | — | — | US | disclosed |
| EP-0511303-A4 | AMINOPYRIDYL SILANES AND SILOXANES | — | 1993-09-01 | — | — | EP | disclosed |
| WO-1993008150-A1 | HYDROLYZING ESTERS USING 4-AMINOPYRIDYL SILOXANE CATALYSTS | INDIANA UNIVERSITY FOUNDATION (US) | 1993-04-29 | — | — | WO | disclosed |
| US-5194555-A | Incorporating dialkylaminopyridine functionality; catalyst for acylation, polymerization, reduction, oxidation | INDIANA UNIVERSITY FOUNDATION (US) | 1993-03-16 | — | — | US | disclosed |
| EP-0511303-A1 | AMINOPYRIDYL SILANES AND SILOXANES | INDIANA UNIVERSITY FOUNDATION (US) | 1992-11-04 | — | — | EP | disclosed |
| WO-1991010714-A1 | AMINOPYRIDYL SILANES AND SILOXANES | INDIANA UNIVERSITY FOUNDATION (US) | 1991-07-25 | — | — | WO | disclosed |
| US-4997944-A | Catalysts, polymer precursor | INDIANA UNIVERSITY FOUNDATION (US) | 1991-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090082588-A1 | Process for producing fluorinated carbamates and isocyanates | SRM, CA4, PRMT3 | CHRM5 1816/4885CHKA 338/4885SLC6A2 3817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.